The Graft-Versus-Leukemia Effect in AML

The Graft-Versus-Leukemia Effect in AML

Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the most established and commonly used cellular immunotherapy in cancer care. It is the most potent anti-leukemic therapy in patients with acute myeloid leukemia (AML) and is routinely used with curative intent in patients with interme...

Full description

Bibliographic Details
Main Authors:	Connor Sweeney, Paresh Vyas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Series:	Frontiers in Oncology
Subjects:	acute myeloid leukemia stem cell transplantation graft-versus-leukemia graft-versus-host disease T cells antigens
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.01217/full

Similar Items

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

Graft versus host disease in a patient with chronic granulocytic leukemia who received an hematopoietic progenitor cell transplant
by: Marta Zapata-Tarrés, et al.
Published: (2014-07-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation
by: Mahdiyar Iravani Saadi, et al.
Published: (2022-10-01)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

A case of psoriasiform graft-versus-host disease
by: Jinping HUANG, et al.
Published: (2022-06-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
by: Jingjing Han, et al.
Published: (2017-11-01)

Polymyositis as a Rare Musculoskeletal Manifestation of Chronic Graft-Versus-Host Disease: A Case Report of a 33-Year-Old Patient
by: David Ben-Nun
Published: (2020-04-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Metabolic instruction of the graft-versus-leukemia immunity
by: Ann-Cathrin Burk, et al.
Published: (2024-03-01)

Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
by: Guancui Yang, et al.
Published: (2022-10-01)

Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect
by: H. Moses Murdock, et al.
Published: (2024-03-01)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
by: Ying-Jun Chang, et al.
Published: (2021-10-01)

Thoracic air leak syndrome as the sole manifestation of chronic lung graft-versus-host disease: a case report
by: Avinash Anil Nair, et al.
Published: (2022-11-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
by: Malte Roerden, et al.
Published: (2020-07-01)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
by: Annalisa Ruggeri, et al.
Published: (2018-03-01)

Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease
by: Wang QY, et al.
Published: (2019-12-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
by: Nona Janikashvili, et al.
Published: (2021-01-01)

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation
by: Eva A. S. Koster, et al.
Published: (2024-03-01)

Graft-versus-host disease complicated with small bowel obstruction in children: A case report
by: Yizhong Wang, et al.
Published: (2022-09-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
by: Israel Henig, et al.
Published: (2014-10-01)

Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report
by: Yili Fan, et al.
Published: (2023-12-01)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
by: Fathima A. Mohamed, et al.
Published: (2021-10-01)

Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse
by: Ivan Odak, et al.
Published: (2022-10-01)

The EBMT Risk Score in the Presence of Graft Versus Host Disease in Allogeneic Stem Cell Transplantation in Adult Acute Myelogenous Leukemia: A Multistate Model for Competing Risks
by: Arash Jalali, et al.
Published: (2014-09-01)

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation
by: Farnsworth Paul, et al.
Published: (2012-09-01)

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration
by: Yang Gao, et al.
Published: (2021-12-01)

The impact of regulatory T cells on the graft-versus-leukemia effect
by: Carolina P. Pacini, et al.
Published: (2024-04-01)

Shellfish allergy–induced overlap chronic graft-versus-host disease
by: Hayley Anne Braun, MD, MPH, et al.
Published: (2021-11-01)